SEC Form 4/A · accession 0000899243-17-021360
Clovis Oncology, Inc. · CLVS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Corwin Dale Hooks
Officer — See Remarks
Period of report
Aug 29, 2017
Accepted (ET)
Sep 1, 2017 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001466301
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 29, 2017 | F | 1,325 | $72.14 | D | 2,150 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This Amendment is being filed to correct the sale price and the number of shares sold to satisfy the tax withholding obligations in connection with the vesting and settlement of the Restricted Stock Units reported in the original Form 4.
Remarks
Senior Vice President and Chief Commercial Officer